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Pharyngocutaneous fistula following total laryngectomy
Abstract
Felipe Toyama Aires1, Rogério Aparecido Dedivitis2, Mario Augusto Ferrari de Castro3, Daniel Araki Ribeiro4, 
Claudio Roberto Cernea5, Lenine Garcia Brandão6
Pharyngocutaneous fistula (PCF) is the most common complication after total laryngectomy.
Objectives: To establish the incidence of this complication and to analyze the predisposing factors.
Method: This is a cross-sectional study of a historical cohort including 94 patients who underwent 
total laryngectomy. The following aspects were correlated to the occurrence of PCF: gender, age, 
tumor site, TNM staging, type of neck dissection, previous radiation therapy, previous tracheotomy, 
and use of stapler for pharyngeal closure. The following were considered in PCF cases: the day into 
postoperative care when the fistula was diagnosed, duration of occurrence, and proposed treatment.
Results: Twenty (21.3%) patients had PCF. The incidence of PCF was statistically higher in T4 
tumors when compared to T2 and T3 neoplasms (p = 0.03). The other analyzed correlations were 
not statistically significant. However, 40.9% of the patients submitted to tracheostomy previously 
had fistulae, against 21.1% of the patients not submitted to this procedure.
Conclusion: Advanced primary tumor staging is correlated with higher incidences of PCF.
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INTRODUCTION
Pharyngocutaneous fistula (PCF) is the most 
commonly reported postoperative complication in to-
tal laryngectomy patients. PCF significantly increases 
morbidity, length of hospitalization, and cost of care, 
in addition to delaying the start of indicated adjuvant 
therapy1. Salivary fistulae also predispose patients 
to neck large vessel injuries and cause considerable 
discomfort as patients have to be fed through naso-
gastric tubes2. The literature reports PCF incidence 
rates ranging from 3% to 65%3-5.
Many factors related to the incidence of PCF 
such as age, gender, smoking and alcohol con-
sumption during the disease, liver function, anemia, 
previous radiotherapy, previous tracheostomy, neck 
dissection, comorbidities (diabetes, decompensated 
congestive heart failure, malnutrition, chronic bron-
chitis) and even postoperative vomiting have been 
the topic of controversy. The factors known to be 
associated with increased incidence are inadequate 
surgery, and hematoma of the surgical wound. In 
cases of late fistulization, second primary tumor of 
the piriform sinus must be considered6-10.
This paper aimed to establish the incidence of 
this complication and analyze predisposing factors in 
a series of patients seen at a specialized care center.
METHOD
This study was approved by the Research 
Ethics Committee of the institution in which it was 
carried out. This retrospective cohort study included 
the analysis of the charts of patients diagnosed with 
laryngeal squamous cell carcinoma (SCC) submitted 
to total laryngectomy in two tertiary care hospitals. 
All procedures were performed by two surgeons, 
who followed all the patients and tracked the pos-
toperative onset of PCF.
From 1996 to 2011, 94 patients underwent total 
laryngectomy. These patients were studied retros-
pectively for the occurrence of PCF. The following 
variables were considered: gender, age, primary tu-
mor site, primary tumor TNM staging, type of neck 
dissection, previous radiotherapy, previous trache-
ostomy, and the use of manual stitches or stapler 
to close the pharynx. Total laryngectomy patients 
diagnosed with SCC by biopsy were enrolled in the 
study. Indication of pharyngeal flap closure was 
considered as a criterion for exclusion.
As a routine, patients were given a prophylactic 
combination of antibiotics amikacin and clindamycin 
during the first day after surgery, with the first dosage 
given at the time of anesthesia induction. Subjects un-
derwent primary closure of the pharyngeal remnant 
without flap rotation. Flap surgery was a criterion for 
subject exclusion.
Two types of pharyngeal closure procedures 
were performed: manual closure using T-shaped 
stitches with polyglactin 3-0; and closure with a 75 
mm TCL75 Ethicon® linear stapler. The stapler was 
first used in 2003. As a routine, a primary tracheoe-
sophageal fistula was not created during surgery to 
place the voice prosthesis. The prosthesis was put 
in place three months after surgery.
In PCF cases, the day of PCF onset into pos-
toperative care, duration, length of hospitalization, 
therapy, and patient evolution were considered. Diag-
nosis was done through the observation of saliva se-
cretion in the continuous suction tube. Patients were 
given methylene blue to facilitate fistula visualization.
Nasoenteral feeding tubes were placed on the 
first day after surgery. Oral feeding was initiated on 
day 10 after surgery in PCF-negative patients. Late 
fistulization was not observed in patients cleared for 
oral feeding on day 10 after surgery.
Dichotomic data univariate analysis was per-
formed using a 2x2 matrix and the chi-square test. 
Continuous data sets were analyzed by the difference 
between mean values and their respective standard 
deviations. A p-value of 0.05 was adopted.
RESULTS
Ninety-four laryngeal SCC patients submitted 
to total laryngectomy were analyzed. Eighty-seven 
were males (92.5%). Subject age ranged from 36 to 
89 years, and mean age was 62.0 ± 11.2 years.
The global incidence of PCF was 21.3% (20 
subjects). In the group with PCF, 85% were treated 
conservatively with antibiotics, enteral feeding, local 
hygiene, and neck compression. The three patients 
treated surgically were offered the myocutaneous flap 
procedure.
The outcomes concerning the analyzed predis-
posing factors can be seen on Table 1.
Seven patients had T2 tumors, 64 had T3 di-
sease, and 23 had T4 neoplasms. Patients diagnosed 
with advanced disease (T4) were at increased risk of 
78(6) - inglês.indb   95 12/12/2012   09:19:17
96
Brazilian Journal of otorhinolaryngology 78 (6) novemBer/DecemBer 2012
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
Our patients had PCF from three to eight days after 
surgery. Mean length of hospitalization was 12.8 days, 
against three days for the non-PCF group. Patients 
were discharged as early as possible, even when they 
had pharyngeal fistula (PF), and kept in home care.
In terms of primary tumor site, patients with 
supraglottic tumors were at a higher risk for PCF, as 
in these cases subjects may be submitted to large 
resections of the pharyngeal mucosa and the stitches 
might be under significant strain5. In another series, 
only the patients submitted to combined partial pha-
ryngectomy and total laryngectomy procedures were 
statistically at risk of PCF2. In our series, the higher 
prevalence of glottic tumors did not allow further 
comparison. Additionally, patients who required 
more extensive resection of the pharyngeal mucosa 
had their reconstructions done with flaps, which 
excluded them from the study.
Some authors have found that neck dissection 
done concurrently to total laryngectomy increased the 
incidence of PCF5,11. This variable was not statistically 
significant in our sample (p = 0.81).
There is disagreement in the literature in re-
gards to the impact of previous radiotherapy. Some 
authors found it not to be statistically significant2,4,5, 
while others found relevant correlations8,12. PCF has 
been reported to occur earlier in previously irradiated 
patients5. There is a 2% to 3% chance of PCF when 
total laryngectomy is performed as the primary treat-
ment, but incidence rates soar to 10% to 12% when 
it is done after radiotherapy, and increase to even 
higher levels when other neck procedures and/or 
more extensive surgery are performed10. Radiotherapy 
dosages greater than 5,000 cGy have been reported 
to increase PCF incidence rates13. Another study 
reported rates of 80% among surgery patients given 
6,800 to 7,200 cGy14.
Organ preservation protocols have been 
considered as an important option in the treatment 
of advanced laryngeal cancer. However, it is yet 
unknown whether the addition of chemotherapy 
and radiotherapy increases the chance of postope-
rative complications in the context of salvage total 
laryngectomy. In a prospective randomized trial 517 
patients were divided into three arms: 1) induction 
chemotherapy followed by radiotherapy; 2) chemora-
diotherapy; and 3) radiotherapy alone. PCF incidence 
rates were lower in the third arm (15%) and higher 
in the second (30%)15. Our study featured a group 
Table 1. Correlation between variables and incidence of pha-
ryngocutaneous fistula.
Variable PCF n = 20 No PCF n = 74 p
Gender
Male 19 68
0.59
Female 1 6
Age
≤ 60 4 24
0.24
> 60 16 50
T-stage
T2/T3 11 60
0.03
T4 9 14
Tracheostomy
Yes 9 22
0.22
No 11 52
Previous chemoradiotherapy
Yes 8 24
0.54
No 12 50
Neck disection
Radical 13 46
0.81
Selective 7 28
Pharyngeal closure
Manual 14 60
0.32
Stapler 6 14
PCF by an additional 24% when compared to subjects 
with T2-T3 disease (39.1% vs. 15.5%, respectively; 
95% CI 0.02 to 0.45; p = 0.03).
Thirty-one patients had undergone tracheos-
tomy before surgery. Nine of them had PCF after 
laryngectomy. Tracheostomy did not increase the risk 
of PCF (p = 0.22). However, 40.9% of the patients 
who had undergone tracheostomy before surgery had 
fistulae, against 21.1% of the subjects not submitted 
to tracheostomy. Age, type of neck dissection and 
pharyngeal closure were not statistically significant.
Our patients had PCF from days 3 and 8 after 
surgery. Mean length of hospitalization was 12.8 days, 
against three days for the non-PCF group.
DISCUSSION
The approach chosen to treat PCF may consi-
derably increase the length of hospitalization and cost 
of care, in addition to delaying the start of adjuvant 
radiotherapy when indicated. PCF is a complication 
that usually occurs shortly after total laryngectomy. 
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with previous chemoradiotherapy (organ preserva-
tion protocol) and salvage total laryngectomy for 
relapsing and residual disease (n = 32) and a group 
with laryngectomy as the primary therapy (n = 62), 
but their PCF incidence rates were not statistically 
different (p = 0.54).
Tracheostomy did not increase the risk of PCF 
(p = 0.22). However, 40.9% of the patients who had 
undergone tracheostomy before surgery had fistu-
lae, against 21.1% of the subjects not submitted to 
tracheostomy. It is possible that a larger sample of 
patients could elicit the significance of this trend. A 
study done with 55 patients found significantly hi-
gher rates of PCF in patients previously submitted to 
tracheostomy (60% vs. 8%) - p = 0.01216. The possible 
explanations for this finding include more advanced 
disease, fibrosis, and local contamination by tracheal 
secretion. Indeed, tracheostomy is frequently offered 
to patients manifesting respiratory insufficiency on 
their first visit with the specialized physician, a sign 
of advanced primary tumor17. And the T-stage was 
considered in our study as a statistically significant 
factor for the occurrence of PCF.
Blood transfusions were not considered in the 
assessment done in this study, as they were rarely 
offered during surgery. But this is a controversial 
topic in the literature. While one study reports a 
28% incidence rate of PCF in patients given blood 
product transfusions against a 7% rate for patients 
not given transfusion18, other authors failed to find 
such correlation1,19. Transfusion is more indicated 
in larger procedures, usually associated with more 
advanced disease.
Pharyngeal closure using linear staplers during 
total laryngectomy has become more popular in the 
last three decades20. Manual stitches take longer, 
lead to more necrosis of the pharyngeal mucosa, 
and contamination of the surgery site with saliva. 
Additionally, there is a weak spot in manual laryngeal 
closure: the junction point in the T-shaped stitches. 
This weak spot is not produced when a stapler is 
used. Stapling reduces the rate of PCF, as revealed 
in a meta-analysis21.
Another factor correlated to early PCF is histo-
logical infiltration in the surgical margins of the tumor 
- 11% negative vs. 38% positive9. This variable was 
not considered in our study, as intraoperative histo-
pathology testing of the frozen margins removed from 
the patient was done after the removal of the surgical 
specimen. This was done as a safety measurement. 
On the other hand, part of the tumors, particularly the 
ones removed in stapler-assisted pharyngeal closure, 
are endolaryngeal, in which case broader resection 
margins are available.
Salivary fistulae usually occur between five to 
seven days after surgery. Oral feeding is normally 
reintroduced after this period22. The nasoenteral fee-
ding tube is usually removed ten days after surgery in 
patients without signs of PCF. Studies have recently 
discussed the early reintroduction of oral feeding 
in total laryngectomy patients as a factor that does 
not increase the risk of complication. A case-control 
study revealed that early peroral feeding was not 
considered as a risk factor23.
CONCLUSION
Patients with advanced primary tumors are at 
a higher risk of PCF.
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